📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.trsl.2014.10.010

PubMed Identifier: 25468487

Publication URI: http://europepmc.org/abstract/MED/25468487

Type: Journal Article/Review

Volume: 165

Parent Publication: Translational research : the journal of laboratory and clinical medicine

Issue: 2

ISSN: 1878-1810